• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue2

THREE-DIMENSIONAL PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMA IN MODERN ERA

    Dr. Manraj Singh Kang Dr. Abhilasha Sinha Dr. Taranjeet Kaur Dr. D P Singh

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 2, Pages 1546-1555

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Soft tissue sarcomas (STSs) are a typical group that differs from one of the tumours with distinct histopathological subtypes. It is estimated in 21% of all malignant diseases in children, and less than 1% of all adult malignancies [1] Adjuvant radiation is well-established for the conservative treatment of soft tissue
sarcomas. The National Cancer Comprehensive Cancer Network guidelines recommend that postoperative radiotherapy be administered to most patients with sarcomas of the soft tissues of the extremities and upper extremity. When only low-dose (LDR) brachytherapy (BT) is used, 45-Gy doses are used in patients with severe oedema. In cases where margins are positive, a combination of 50 Gy beam radiotherapy (EBRT) and 16-20 Gy of LDR brachytherapy or equivalent high-dose rate (HDR) is warranted. This range of radiation concentrations produces a five-year cell control rate of 75-90% [3 - 14]. LDR brachytherapy has been a frequently used method [15 - 23], and reports of high-dose (HDR) brachytherapy are very small in number [24 - 27]. However, HDR brachytherapy is widely used due to better compliance with radiation safety policies, more complex radiationplanning and the possibility of outpatient treatment.
Keywords:
    Soft tissue sarcoma Perioperative Brachytherapy
  • PDF (585 K)
  • XML
(2021). THREE-DIMENSIONAL PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMA IN MODERN ERA. European Journal of Molecular & Clinical Medicine, 8(2), 1546-1555.
Dr. Manraj Singh Kang; Dr. Abhilasha Sinha; Dr. Taranjeet Kaur; Dr. D P Singh. "THREE-DIMENSIONAL PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMA IN MODERN ERA". European Journal of Molecular & Clinical Medicine, 8, 2, 2021, 1546-1555.
(2021). 'THREE-DIMENSIONAL PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMA IN MODERN ERA', European Journal of Molecular & Clinical Medicine, 8(2), pp. 1546-1555.
THREE-DIMENSIONAL PERIOPERATIVE HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMA IN MODERN ERA. European Journal of Molecular & Clinical Medicine, 2021; 8(2): 1546-1555.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 126
  • PDF Download: 189
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus